Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,231.8
-7.4 (-0.23%)

 

  • STI Straits Times Index
    3,231.8
    -7.4 (-0.23%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,593.5
    -3.7 (-0.23%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,323.7
    -247.8 (-0.93%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,909.9
    4.6 (0.16%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,141.5
    -178.3 (-0.76%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,098.9
    -43.6 (-0.71%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,139.2
    16.8 (0.79%)
    Index delayed 20 minutes
  • XAO XAO
    6,840.8
    35.2 (0.52%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,018.9M
  • Value: 1,045.8M
  • Rise: 152
  • Fall: 171
  • Unch: 506

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.198+0.005
Golden Agri-Res0.245-0.020
YZJ Shipbldg SGD0.970+0.015
Tritech0.029+0.005
Mapletree NAC Tr1.150-0.010
BreadTalk0.620+0.080
Yoma Strategic0.375+0.050
ComfortDelGro2.320-0.060
Ascendas Reit2.900-0.020
AusGroup^0.030-0.002

World Indices

World Indices
Name Last Change
Nasdaq 8,482.1 -4.0
HSI 26,323.7 -247.8
HSCEI 10,427.4 -91.7
Jakarta 6,098.9 -43.5
Nikkei 225 23,141.5 -178.3
SSE Comp 2,909.9 +4.6
Shanghai A 3,048.6 +4.9
Shanghai B 258.2 -0.4
PSE Comp 0.0
KOSPI 2,139.2 +16.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

OCUGEN INC OCUGEN
Updated on 13 Nov 2019 (End of trading day)
Last (USD): 0.573 Change: -0.117 High: 0.681 Remarks: -
Change (%): -16.89 Low: 0.531
Open 0.670 Yesterday's Close 0.6897000000000001
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 3,801,402 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.53250 Trailing EPS (USD) e -0.23257 NAV (USD) b -0.5456
PE a - Trailing PE f - Price / NAV b -1.0506
Dividend (USD) d - Cash In Hand (USD) g 0.1741 Issued & Paid-up Shares c 16,003,900
Dividend Yield (%) d - Price / Cash In Hand g 3.292 Treasury Shares h -
Beta - 75 Daysi -2.047 R-Squared - 75 Days(%)i 0.11 Market Cap (M) 9.173
Beta - 500 Daysi -1.353 R-Squared - 500 Days (%)i 0.46 Enterprise Value (M) 6.387
Piotroski F Score 2 Exchange Code OCGN Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 60.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 13 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 30 Sep 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference OCUGEN INC NASDAQ 9.173 - - -1.0506 -
Industry Biotechnology NASDAQ 2,353.889 138.401 139.569 5.4786 0.741
Local Peer AMGEN INC NASDAQ 130,524.399 15.550 16.180 11.9451 2.547
Local Peer GILEAD SCIENCES INC NASDAQ 80,121.950 14.688 29.752 3.8887 3.648
Local Peer CELGENE CORP NASDAQ 78,580.343 19.422 13.364 6.5012 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 53,255.765 25.403 24.842 10.1374 -
Local Peer BIOGEN INC NASDAQ 50,864.795 11.480 9.427 3.6343 -
Local Peer ILLUMINA INC NASDAQ 43,838.340 53.073 45.055 9.8757 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 38,241.936 15.645 17.835 3.6406 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 23,706.905 305.501 16.124 2.2867 -
Local Peer SEATTLE GENETICS INC NASDAQ 19,231.223 - - 10.8065 -
Local Peer INCYTE CORPORATION NASDAQ 18,832.160 171.995 46.503 7.7738 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 13,676.647 - - 4.4485 -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 12,355.852 - 39.811 4.4703 -
Other Local Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), REPLIGEN CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), ALKERMES PLC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), VIELA BIO INC (NASDAQ), EPIZYME INC (NASDAQ), REGENXBIO INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VERACYTE INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ARVINAS INC (NASDAQ), ALECTOR INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), OPKO HEALTH INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), INTREXON CORP (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), OMEROS CORP (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CORTEXYME INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), TRANSLATE BIO INC (NASDAQ), RETROPHIN INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), CHEMOCENTRYX INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SYNTHORX INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), IMMUNOGEN INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MORPHIC HOLDING INC (NASDAQ), MERUS B V (NASDAQ), DERMIRA INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MACROGENICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ARDELYX INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), COMPUGEN (NASDAQ), PERSONALIS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), RESTORBIO INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), GERON CORP (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MANNKIND CORPORATION (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CABALETTA BIO INC (NASDAQ), XOMA CORP (NASDAQ), ATHERSYS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), AFFIMED N V (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), IMV INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), CHIMERIX INC (NASDAQ), NOVAVAX INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NANTKWEST INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), COHBAR INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SYNLOGIC INC (NASDAQ), VERASTEM INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), TREVENA INC (NASDAQ), VACCINEX INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), INFLARX N V (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), VERMILLION INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), ORGENESIS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CURIS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), INMUNE BIO INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), SAVARA INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ZAFGEN INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), CONTRAFECT CORP (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SENESTECH INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), VAXART INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), BIOCEPT INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), TOCAGEN INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), TROVAGENE INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 20 ORD SHS (NASDAQ), ADVAXIS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SPHERIX INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), OPGEN INC (NASDAQ)
Global Peer CSL ASX 122,394.584 45.620 45.620 16.3560 0.984
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,878.551 75.565 22.275 5.0302 0.794
Global Peer SINO BIOPHARM HKEx 141,591.961 13.214 13.638 4.1598 0.650
Global Peer WUXI BIO HKEx 109,919.266 147.165 115.050 11.3148 -
Global Peer BEIGENE HKEx 92,176.258 - - 7.5930 -
Global Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Global Peer GENSCRIPT BIO HKEx 32,909.233 197.915 - 9.2806 -
Global Peer 3SBIO HKEx 32,105.221 21.223 25.832 3.1644 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,824.349 45.045 656.825 2.7288 -
Other Global Peers HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), CKLIFE SCIENCES (HKEx), POLYNOVO LIMITED (ASX), VIVA BIOTECH (HKEx), ASCENTAGE-B (HKEx), AVITA MEDICAL LTD (ASX), MESOBLAST LTD (ASX), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), MYOVANT SCIENCES LTD (NYSE), ESSEX BIO-TECH (HKEx), KADMON HLDGS INC (NYSE), ARCUS BIOSCIENCES INC (NYSE), STARPHARMA HOLDINGS LIMITED (ASX), TELIX PHARMACEUTIC (ASX), LEE'S PHARM (HKEx), NEXT SCIENCE LTD (ASX), PFENEX INC (NYSE American), DPHARMA (Bursa), NEUREN PHARMACEUTICALS LTD (ASX), 22ND CENTURY GROUP INC (NYSE American), BBI LIFE SCI (HKEx), UNI-BIO GROUP (HKEx), ENZO BIOCHEM INC (NYSE), NANOVIRICIDES INC (NYSE American), RESAPP HEALTH LIMITED (ASX), PALATIN TECHNOLOGIES INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), PHYLOGICA LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), IMUGENE LIMITED (ASX), ONCOSIL MEDICAL LIMITED (ASX), CEL-SCI CORP (NYSE American), ORTHOCELL LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), PORT (SET), ARMATA PHARMACEUTICALS INC (NYSE American), BIONOMICS LTD (ASX), NOVITA HEALTHCARE LTD (ASX), REGENT PACIFIC (HKEx), ACTINOGEN MEDICAL LTD (ASX), BIOTRON (ASX), MEMPHASYS LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), BIOSINO BIO-TEC (HKEx), RHINOMED LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), ORAGENICS INC (NYSE American), EXTRAWELL PHAR (HKEx), ISORAY INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), PROTEOMICS INTL LABORATORIES LTD (ASX), IMMURON LIMITED (ASX), IBIO INC (NYSE American), ADALTA LTD (ASX), PATRYS LIMITED (ASX), Suntar Eco-City^ (SGX), REGENEUS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), CELLMID LIMITED (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), BENITEC BIOPHARMA LTD (ASX), GENETIC TECHNOLOGIES (ASX), MEGASUN (Bursa), AUSTRALIAN PRIMARY HEMP LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), BIOXYNE LIMITED (ASX), HAO WEN HLDGS (HKEx), MGRC (Bursa), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), IMMUTEP LTD (ASX), MEDIBIO LIMITED (ASX), TBG DIAGNOSTICS LTD (ASX), AIM IMMUNOTECH INC (NYSE American), QT Vascular (SGX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.587
-50.59 %
10 Days --1.047
-64.62 %
20 Days --1.247
-68.51 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.680 - 8.620 Change From 1 Year Low -0.107 % Change From 1 Year Low (%) -15.71
Change From 1 Year High -8.047 % Change From 1 Year High (%) -93.35
2 Years Range 0.680 - 8.620 Change From 2 Years Low -0.107 % Change From 2 Years Low (%) -15.71
Change From 2 Years High -8.047 % Change From 2 Years High (%) -93.35
5 Years Range 0.680 - 8.620 Change From 5 Years Low -0.107 % Change From 5 Years Low (%) -15.71
Change From 5 Years High -8.047 % Change From 5 Years High (%) -93.35
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Ocugen, Inc. engages in the development and commercialization of therapies for eye diseases. Its pipeline of therapies includes OCU400, OCU410, OCU200, OCU100, and OCU300. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA.

Historical Price Data

Date Open High Low Close Volume VWAP
13 Nov 2019 0.670 0.681 0.531 0.573 3,801,402 -
12 Nov 2019 0.834 0.834 0.680 0.690 3,064,839 -
11 Nov 2019 0.870 0.880 0.755 0.841 3,504,046 -
08 Nov 2019 1.210 1.210 1.000 1.000 3,825,980 -
07 Nov 2019 1.300 1.300 1.120 1.160 1,781,618 -
06 Nov 2019 1.450 1.450 1.280 1.310 1,613,342 -
05 Nov 2019 1.530 1.530 1.440 1.450 513,177 -
04 Nov 2019 1.530 1.580 1.480 1.520 338,921 -
01 Nov 2019 1.600 1.600 1.460 1.520 588,627 -
31 Oct 2019 1.530 1.770 1.510 1.620 970,525 -
30 Oct 2019 1.480 1.530 1.420 1.520 388,130 -
29 Oct 2019 1.600 1.609 1.470 1.500 919,620 -
28 Oct 2019 1.730 1.780 1.670 1.670 437,906 -
25 Oct 2019 1.900 1.900 1.740 1.760 811,587 -
24 Oct 2019 1.900 1.920 1.820 1.900 420,946 -
23 Oct 2019 1.900 1.989 1.750 1.910 951,133 -
22 Oct 2019 1.980 2.050 1.880 1.970 619,116 -
21 Oct 2019 2.130 2.380 1.950 2.010 1,814,063 -
18 Oct 2019 1.810 2.190 1.750 2.150 3,157,408 -
17 Oct 2019 2.050 2.100 1.790 1.820 1,958,734 -
16 Oct 2019 1.640 2.730 1.530 2.070 10,566,400 -
15 Oct 2019 1.430 1.550 1.300 1.530 2,221,644 -
Summary
Current 2 Weeks
(31 Oct 2019 to 13 Nov 2019)
1.530 1.770 0.531 0.573 20,002,477 -
Previous 2 Weeks
(17 Oct 2019 to 30 Oct 2019)
2.050 2.100 0.531 1.520 11,478,643 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.